NO20101070L - Fremgangsmate til dosering av et medikament, samt doseringsform - Google Patents

Fremgangsmate til dosering av et medikament, samt doseringsform

Info

Publication number
NO20101070L
NO20101070L NO20101070A NO20101070A NO20101070L NO 20101070 L NO20101070 L NO 20101070L NO 20101070 A NO20101070 A NO 20101070A NO 20101070 A NO20101070 A NO 20101070A NO 20101070 L NO20101070 L NO 20101070L
Authority
NO
Norway
Prior art keywords
drug
dosing
well
dosage form
dosage forms
Prior art date
Application number
NO20101070A
Other languages
English (en)
Other versions
NO333360B1 (no
Inventor
Andrew C Lam
Atul Devdatt Ayer
Jeri Dawn Wright
Carol A Christopher
Diane R Guinta
Suneel K Gupta
Lawrence Hamel
Zahedeh Hatamkhany
Samuel R Saks
Padmaja Shivanand
Richard G Weyers
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1999/011920 external-priority patent/WO1999062496A1/en
Publication of NO20101070L publication Critical patent/NO20101070L/no
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO333360B1 publication Critical patent/NO333360B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/88—Investigating the presence of flaws or contamination
    • G01N21/95—Investigating the presence of flaws or contamination characterised by the material or shape of the object to be examined
    • G01N21/9508—Capsules; Tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det omtales fremgangsmåter og anordninger for å opprettholde en ønsket terapeutisk medikamentvirkning over et forlenget terapitidsrom. Særlig frembringes det orale doseringsformer som frigir medikament i den gastrointestinale kanal ved en stigende frigivningshastighet over et forlenget tidsrom. Doseringsformene kan dessuten omfatte en medikamentdose som frigis umiddelbart.
NO20101070A 1998-06-03 2010-07-27 Doseringsform til dosering av et medikament, samt anvendelse. NO333360B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8778798P 1998-06-03 1998-06-03
PCT/US1999/011920 WO1999062496A1 (en) 1998-06-03 1999-05-27 Methods and devices for providing prolonged drug therapy

Publications (2)

Publication Number Publication Date
NO20101070L true NO20101070L (no) 2001-02-05
NO333360B1 NO333360B1 (no) 2013-05-13

Family

ID=27733446

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20101070A NO333360B1 (no) 1998-06-03 2010-07-27 Doseringsform til dosering av et medikament, samt anvendelse.
NO20130342A NO334409B1 (no) 1998-06-03 2013-03-06 Framgangsmåte til framstilling av en oral doseringsform

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20130342A NO334409B1 (no) 1998-06-03 2013-03-06 Framgangsmåte til framstilling av en oral doseringsform

Country Status (6)

Country Link
US (3) US7521067B1 (no)
JP (2) JP2012082195A (no)
KR (1) KR100827254B1 (no)
IL (3) IL140020A (no)
NO (2) NO333360B1 (no)
ZA (1) ZA200007111B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100827254B1 (ko) 1998-06-03 2008-05-07 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
ES2909803T3 (es) 2018-03-05 2022-05-10 Amneal Complex Products Res Llc Composiciones farmacéuticas programables para la cronoliberación de fármacos
CA3097468A1 (en) * 2018-04-16 2019-10-24 S&R Farmaceutici S.P.A. Mixture of resveratrol supported on metal hydroxide and non-supported pure resveratrol for treating female fertility
EP3970701B1 (en) * 2018-06-27 2025-05-07 Amneal Complex Products Research LLC Self-regulating osmotic gastroretentive drug delivery systems
MX2021008933A (es) * 2019-01-25 2021-08-24 Ironshore Pharmaceuticals & Dev Inc Composiciones metilfenidato para tratamiento de trastorno de hiperactividad por deficit de atencion.
US11547670B2 (en) 2019-03-05 2023-01-10 Amneal Complex Products Research Llc Delayed release methylphenidate compositions
EP3986382A1 (en) * 2019-06-21 2022-04-27 Kashiv Biosciences, LLC Gastroretentive dosage forms of levodopa and carbidopa
US11964048B2 (en) 2020-12-18 2024-04-23 Amneal Complex Products Research Llc Sustained release compositions comprising liothyronine

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB952006A (en) 1962-02-21 1964-03-11 John Holroyd & Company Ltd Multi-layer tablet making machines
US3634584A (en) 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
US4093708A (en) 1974-12-23 1978-06-06 Alza Corporation Osmotic releasing device having a plurality of release rate patterns
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4591500A (en) 1983-04-25 1986-05-27 Microencapsulation S.A. Tablet having the shape of a capsule, process and device for its preparation
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4847093A (en) 1986-06-19 1989-07-11 Alza Corporation Dosage form with means for governing rate of gas formation
US4874388A (en) 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US5236689A (en) 1987-06-25 1993-08-17 Alza Corporation Multi-unit delivery system
US5391381A (en) 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
US4915953A (en) 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering acetaminophen or phenylpropanolamine
JP2770243B2 (ja) 1989-09-21 1998-06-25 ライオンエンジニアリング株式会社 錠剤成分量検査方法およびその装置
US5213738A (en) 1990-05-15 1993-05-25 L. Perrigo Company Method for making a capsule-shaped tablet
US5089270A (en) 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5464631A (en) 1990-06-27 1995-11-07 Warner-Lambert Company Encapsulated dosage forms
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5190765A (en) 1991-06-27 1993-03-02 Alza Corporation Therapy delayed
US5160744A (en) 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5294770A (en) * 1992-01-14 1994-03-15 Alza Corporation Laser tablet treatment system with dual access to tablet
US5248310A (en) * 1992-03-27 1993-09-28 Alza Corporation Oral osmotic device with hydrogel driving member
US5422831A (en) 1992-08-03 1995-06-06 Iowa State University Research Foundation, Inc. Acoustic and video imaging system for quality determination of pharmaceutical products
DE4417015A1 (de) 1994-05-14 1995-11-16 Maschimpex Gmbh Sortierautomat zur Sortierung bzw. Klassifikation von Kleinprodukten der pharmazeutischen und der Süßwarenindustrie nach Form und Farbe
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.
DK0957899T3 (da) * 1996-08-16 2003-04-22 Alza Corp Doseringsform til tilvejebringelse af stigende dosis lægemiddel
US5824338A (en) 1996-08-19 1998-10-20 L. Perrigo Company Caplet and gelatin covering therefor
ES2262174T3 (es) * 1996-09-30 2006-11-16 Alza Corporation Forma de dosificacion y procedimiento de administracion de medicamentos.
PT946151E (pt) 1996-11-25 2006-07-31 Alza Corp Forma de dosagem de dose crescente
IL128043A (en) * 1997-05-30 2004-08-31 Osmotica Corp Multi-layered osmotic device for controlled delivery of active agents
KR100827254B1 (ko) * 1998-06-03 2008-05-07 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치

Also Published As

Publication number Publication date
IL140020A (en) 2012-10-31
IL222437A (en) 2015-10-29
NO333360B1 (no) 2013-05-13
JP2015028095A (ja) 2015-02-12
NO20130342L (no) 2001-02-05
NO334409B1 (no) 2014-02-24
KR100827254B1 (ko) 2008-05-07
US20130043612A1 (en) 2013-02-21
KR20010043980A (ko) 2001-05-25
US8936810B2 (en) 2015-01-20
US20090186085A1 (en) 2009-07-23
JP2012082195A (ja) 2012-04-26
IL211081A0 (en) 2011-04-28
ZA200007111B (en) 2001-06-05
US7521067B1 (en) 2009-04-21
US8323691B2 (en) 2012-12-04

Similar Documents

Publication Publication Date Title
NO20006007L (no) Fremgangsmåte til dosering av et medikament, samt doseringsform
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
WO2003077972A8 (en) Implantable drug delivery system
NO20063373L (no) CD40-antistoff-formuleringer og fremgangsmater
YU36700A (sh) Oralni farmaceutski oblik za doziranje sa produženim oslobađanjem
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
DK0998287T3 (da) Anvendelse af levobupivacain
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
NO20031409L (no) Ionestyrkeuavhengig farmasoytiske preparat med langvarig frigivelse
WO2005055955A3 (en) DOSING METHODS FOR ß-D-2’,3’-DIDEOXY-2’,3’-DIDEHYDRO-5-FLUOROCYTIDINE ANTIVIRAL THERAPY
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
WO2005004854A3 (fr) Utilisation de la betaine pour le traitement des arterites
NO20042758L (no) Fremgangsmate for behandling av en pasient som krever analgesi.
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
NO20050771L (no) Bicifadinformulering
WO2004037199A3 (en) Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
WO2004010934A3 (en) Methods for the use of neurotoxin in the treatment of urologic disorders
GEP201606538B (en) Preoperative treatment of post operative pain
AP1736A (en) Oral dosage form for controlled drug release.
SE0102887D0 (sv) New formulation
EA200401454A1 (ru) Новая комбинация из обратимо действующих ингибиторов протонного насоса и используемых в терапии дыхательных путей лекарственных веществ, предназначенных для лечения респираторных заболеваний
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
RU2000110676A (ru) Способ консервативного лечения стриктур уретры
WO2003024394A3 (en) Method of treating benign prostatic hyperplasia and other beingn porstate conditions

Legal Events

Date Code Title Description
MK1K Patent expired